Person · CIK 1357522

Peter A. Thompson

Fetching the filing list from SEC EDGAR. This page refreshes on its own.

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Recent filings so far

17 recent filings already on SEC Tracker. The full history, totals and holdings follow when the read from SEC EDGAR finishes.

FiledFormCompanySummary
2026-11-044Aspen Neuroscience, Inc. (ASPE)Peter A. Thompson (Director) bought 1,000,000 ASPE at $15.00, worth $15M
2026-10-293Thompson Peter A. (ASPE)Aspen Neuroscience reports ownership changes
2026-07-094Sionna Therapeutics, Inc. (SION)
2026-07-024Sionna Therapeutics, Inc. (SION)
2026-06-264ARS Pharmaceuticals, Inc. (SPRY)
2026-06-184Sionna Therapeutics, Inc. (SION)
2026-06-174Edgewise Therapeutics, Inc. (EWTX)
2026-06-154Corvus Pharmaceuticals, Inc. (CRVS)
2026-05-294Sionna Therapeutics, Inc. (SION)
2026-05-114Sionna Therapeutics, Inc. (SION)
2026-04-214Sionna Therapeutics, Inc. (SION)
2026-04-164Sionna Therapeutics, Inc. (SION)
2026-02-044Sionna Therapeutics, Inc. (SION)
2026-01-304Corvus Pharmaceuticals, Inc. (CRVS)
2025-12-294Sionna Therapeutics, Inc. (SION)
2025-12-194Sionna Therapeutics, Inc. (SION)
2025-11-264Sionna Therapeutics, Inc. (SION)

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.